Free US stock valuation multiples and PEG ratio analysis to identify reasonably priced growth companies with attractive risk-reward profiles. Our valuation framework helps you find stocks with the right balance of growth and value characteristics for your portfolio. We provide P/E analysis, PEG ratios, and relative valuation metrics for comprehensive valuation coverage. Find value in growth with our comprehensive valuation analysis and multiples tools for growth at a reasonable price strategies.
As of April 7, 2026, Chemed Corp (CHE) trades at a current price of $388.95, marking a 0.67% gain in intraday trading. This analysis examines recent price action, key technical levels, sector context, and potential near-term scenarios for the stock, amid mixed sentiment across the broader healthcare and essential services space. No recent earnings data is available for Chemed Corp as of the date of this analysis, with recent price moves driven largely by market-wide flows and sector trends rathe
What are bearish arguments for Chemed (CHE) Stock | Price at $388.95, Up 0.67% - Gap Down
CHE - Stock Analysis
4,160 Comments
1,452 Likes
1
Trulove
Regular Reader
2 hours ago
A real treat to witness this work.
π 269
Reply
2
Aigner
Consistent User
5 hours ago
This solution is so elegant.
π 233
Reply
3
Nashlie
Daily Reader
1 day ago
Talent and effort combined perfectly.
π 13
Reply
4
Cortlynn
Community Member
1 day ago
Truly a benchmark for others.
π 219
Reply
5
Emmielou
Trusted Reader
2 days ago
Execution is on point!
π 76
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.